Jamie Smith
Media Relations
Email: jamie.smith@molnlycke.com
Phone: +46 723 757507
Gothenburg, Sweden. Wednesday 15 April 2026. Mölnlycke Health Care announces today the appointment of Andreas Johansson as Interim Chief Financial Officer (CFO), with immediate effect.

Following CFO Guillaume Joucla’s appointment as Interim Chief Executive Officer (CEO), Andreas will temporarily move from his current position as Corporate Controller at Mölnlycke to the CFO role, where he will oversee the Finance organisation and Global Business Services. Andreas will in this acting position also be a member of the Mölnlycke Executive Leadership Team.
“Andreas brings strong leadership experience and deep financial expertise from across our four business areas, which will be instrumental when driving both strategic and operational excellence. Together with the team, he will play a key role in advancing our strategy during this time of transition”, says Guillaume Joucla, Interim CEO.
For more information, please contact:

Media Relations
Email: jamie.smith@molnlycke.com
Phone: +46 723 757507
Mölnlycke Health Care has entered an exclusive agreement with AROATM to co-promote EndoformTM in the United States in post-acute settings, effective 16 October 2026.
Atlanta, Georgia. 13 October 2026. No two pairs of hands are the same, yet surgical glove sizing has changed little over time. Mölnlycke Health Care (Mölnlycke®), a global leader in MedTech, is launching MyFit™ by Biogel®, a more inclusive range of surgical glove fit options designed to better reflect the diversity of clinicians’ hand anatomy and help more healthcare professionals find a glove that supports comfort, safety and performance – all critical in the operating room.
Clinicians’ hands can receive up to 1,000 times more radiation than other parts of the body during image-guided procedures1; yet, radiation-attenuating gloves are used in only 10% of applicable cases2, putting healthcare professionals at risk of the damaging effects of radiation.
Gothenburg, Sweden. 16 September 2026. Mölnlycke®, a global leader in MedTech, announces its intention to separate its Operating Room Solutions (ORS) and Gloves businesses into a new standalone company (referred to here as “Mölnlycke Surgical”). The separation is intended to create conditions for both Mölnlycke and Mölnlycke Surgical to reach their full potential and drive value creation long-term.
Mölnlycke Health Care has been honored with the Cardinal Health 2026 Rising Star Award, recognizing outstanding performance as a new member of the Cardinal Health Performance Plus Program.The award was presented during Cardinal Health's National Sales Meeting, held the week of August 9th, and reflects the strength of the partnership between the two organizations across Advanced Wound Care, Patient Positioning, and Antiseptics.
Gothenburg, Sweden. 23 June 2026. Mölnlycke Health Care (Mölnlycke®), a global leader in MedTech, today announces changes to its Board of Directors. Christian Cederholm will leave his Board assignment, while Filippa Stenberg will take his place as member of the Board. Thomas Kidane will step in as deputy board member.
Peachtree Corners, GA. July 7, 2026. Mölnlycke Health Care (Mölnlycke®), a global leader in MedTech, has launched three product innovations in the U.S. since the start of 2026. Designed to expand access to advanced wound care solutions and strengthen the company’s U.S. presence, the portfolio expansion also supports long-term value creation across key market segments.
New white paper calls for integration of environmental, human and economic metrics in sustainability assessments of medical technologies.